Drugs Tested with Lurbinectedin in Trials
Lurbinectedin (Zepzelca), approved for small cell lung cancer (SCLC), shows synergy with irinotecan in preclinical models and early trials. A phase I/II study combined it with irinotecan for relapsed SCLC, reporting objective response rates up to 52% and median progression-free survival of 5.2 months.[1][2]
Common Chemotherapy Combinations
Doxorubicin pairs with lurbinectedin in trials for SCLC and other solid tumors. The ATOM trial tested this doublet post-platinum failure, achieving 46% response rates in sensitive relapse cases.[1][3] Gemcitabine has been evaluated in phase I studies with lurbinectedin for advanced solid tumors, showing tolerability and preliminary activity.[2]
Immunotherapy Pairings
Lurbinectedin synergizes with PD-1 inhibitors like pembrolizumab (Keytruda) in ongoing trials for extensive-stage SCLC. Early data from a phase II study indicate improved response durability when sequenced after immunotherapy.[1][4] Atezolizumab (Tecentriq) appears in combination regimens for first-line SCLC maintenance, leveraging lurbinectedin's DNA repair inhibition to enhance immune checkpoint effects.[3]
Targeted Therapy Combinations
Cyclophosphamide, an alkylating agent, synergizes with lurbinectedin in ovarian cancer trials, with phase Ib data showing safety and 25% response rates.[2] Paclitaxel is under investigation in phase II for endometrial cancer, where the combo exploits microtubule and transcription inhibition for additive effects.[1]
Why These Synergies Work
Lurbinectedin traps DNA-topoisomerase complexes, and pairing it with DNA-damaging agents like irinotecan or doxorubicin amplifies cell death in resistant tumors. Clinical evidence comes from NCI and pharma-sponsored trials, though most combos remain investigational outside SCLC.[1][2]
[1]: FDA Label for Zepzelca
[2]: ClinicalTrials.gov search for lurbinectedin combinations
[3]: Jaspers et al., Lung Cancer (2021) – ATOM trial results
[4]: Trigo et al., Lancet Oncology (2020) – Lurbinectedin monotherapy and combo context